Seanc, to my mind of thinking, after some lengthy trials, and a reasonable period of Trofinetide actually being in the market place where side effects and discontinuation rates were becoming transparent, they were still confident enough in Trof to fork out an extra 100mil to secure the world rights to it. That is all I need to know, apart from a half hour of research, that revealed Cupler as being totally dishonest scumbags that hide their true identities behind multiple companies and are being litigated against for engaging in this illegal behaviour before.
- Forums
- ASX - By Stock
- NEU
- Ann: Comment on research report
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.63%
!
$13.06

Ann: Comment on research report, page-54
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.06 |
Change
0.210(1.63%) |
Mkt cap ! $1.626B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $5.708M | 435.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 1262 | $13.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.06 | 197 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 975 | 13.070 |
9 | 696 | 13.060 |
16 | 1487 | 13.050 |
8 | 1603 | 13.040 |
8 | 2969 | 13.030 |
Price($) | Vol. | No. |
---|---|---|
13.080 | 346 | 7 |
13.090 | 565 | 8 |
13.100 | 1243 | 9 |
13.110 | 1510 | 11 |
13.120 | 1647 | 6 |
Last trade - 14.56pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online